Ligand validation:4AJR

AKG: 2-OXOGLUTARIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4AJR_AKG_A_1418	81%	16%	0.119	0.971	1.93	1.76	1	3	0	0	100%	1
4AJC_AKG_A_502	7%	6%	0.344	0.803	2.77	2.42	1	3	2	0	100%	0.91
1CW4_AKG_A_417	1%	6%	0.361	0.586	3.1	2.09	1	3	3	0	100%	0.5
4QKB_AKG_A_302	100%	20%	0.031	0.994	1.89	1.52	1	1	0	0	100%	1
3GR9_AKG_H_406	100%	10%	0.04	0.995	1.96	2.36	2	5	0	0	100%	1
8X6Q_AKG_D_403	100%	27%	0.041	0.985	1.35	1.58	1	4	0	0	100%	1
8RE9_AKG_A_801	100%	23%	0.04	0.981	1.21	1.95	2	2	0	0	100%	1
8X7C_AKG_B_402	100%	23%	0.041	0.981	1.26	1.92	1	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.